Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06616246 · ClinicalTrials.gov registry record · NA

Training Community Members to be Coaches to Deliver the HealthyLifetime Program

A NA study of Chronic Disease and Health Behaviors, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
2
Study locations

NCT06616246: Recruiting NA study of Chronic Disease and Health Behaviors, sponsored by University of Michigan.

NCT06616246 is a NA study of Chronic Disease and Health Behaviors that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 300 participants, below the 89,937-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06616246, a NA study of Chronic Disease and Health Behaviors, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
2
Study locations

Study Summary

The goal of this randomized controlled study is to learn if, in addition to nurses, community members can be trained as health coaches to deliver the HealthyLifetime (HL) program to people without complex chronic health conditions, an intervention that provides a short-term and effective health coaching intervention delivered through a virtual platform to improve health, resiliency, and independent self-care to participants who are without complex chronic conditions. The main question it aims to answer is: • Can Community Health Coaches achieve the same level of competency and outcome as Nurse Health Coaches in participants without complex chronic conditions?

Primary Outcome

Participants perception of their home and neighborhood on a scale of 1= Extremely Satisfied to 5 = Not at all satisfied

Interventions

  • BEHAVIORAL HealthyLifetime

Study Locations (2)

Michigan

  • University of Michigan - Ann Arbor
  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2025-05-15
Est. Completion 2028-12
Phase NA
University of Michigan

1,327 total trials

What NCT06616246 shows while recruiting

NCT06616246 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 89,937-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower).

The record links to 4 conditions, with Chronic Disease appearing as the primary indexed condition, and to 1 intervention - of which HealthyLifetime is the first listed.

NCT06616246 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06616246 about?

NCT06616246 is a clinical study titled "Training Community Members to be Coaches to Deliver the HealthyLifetime Program". The goal of this randomized controlled study is to learn if, in addition to nurses, community members can be trained as health coaches to deliver the HealthyLifetime (HL) program to people without complex chronic health conditions, an intervention that provides a short-term and effective health coac...

What is the current status of trial NCT06616246?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-05-15. Estimated completion is 2028-12.

What conditions does trial NCT06616246 study?

This clinical trial studies the following conditions: Chronic Disease, Health Behaviors, Functional Decline, Risk Factors.

What interventions are being tested in trial NCT06616246?

The interventions under investigation include: HealthyLifetime (BEHAVIORAL).

Who is sponsoring clinical trial NCT06616246?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06616246 being conducted?

This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06616246's enrollment target sits among peer trials

300 20th of 48 higher than 26 of 48 other Chronic Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06616246, the US trial registry maintained by the National Library of Medicine. NCT06616246 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.